Prioritizing progressive MS rehabilitation research: A call from the International Progressive MS Alliance

Author:

Zackowski Kathleen M1ORCID,Freeman Jennifer2,Brichetto Giampaolo3ORCID,Centonze Diego4,Dalgas Ulrik5ORCID,DeLuca John6,Ehde Dawn7ORCID,Elgott Sara8,Fanning Vanessa9,Feys Peter10ORCID,Finlayson Marcia11ORCID,Gold Stefan M12,Inglese Matilde13,Marrie Ruth Ann14ORCID,Ploughman Michelle15ORCID,Sang Christine N16ORCID,Sastre-Garriga Jaume17ORCID,Sincock Caroline18,Strum Jonathan19,van Beek Johan20,Feinstein Anthony21ORCID

Affiliation:

1. National MS Society, New York, NY, USA

2. School of Health Professions, University of Plymouth, Plymouth UK

3. Research in Rehabilitation, Italian MS Society and Foundation, Milan, Italy

4. Department of Medicine, University of Rome Tor Vergata, Rome, Italy

5. Department of Public Health, Aarhus University, Aarhus, Denmark

6. Department of Research, Kessler Foundation, West Orange, NJ, USA

7. Department of Rehabilitation Medicine, University of Washington Medicine, Seattle, WA, USA

8. Global Director of Patient Affairs, MedDay Pharmaceuticals, Maidenhead, UK

9. People Affected by MS Committee, International Progressive MS Alliance, Canberra, ACT, Australia

10. Department of Rehabilitation Sciences and Physiotherapy, Universiteit Hasselt, Hasselt, Belgium

11. School of Rehabilitation Therapy, Queen’s University, Kingston, ON, Canada

12. Department of Neuropsychiatry, Charitè—University of Medicine Berlin, Berlin, Germany

13. Department of Neurology, Radiology and Neuroscience, Icahn School of Medicine at Mount Sinai, New York, NY, USA

14. Departments of Internal Medicine and Community Health Sciences, University of Manitoba, Winnipeg, MB, Canada

15. Department of Physical Medicine and Rehabilitation, Memorial University of Newfoundland, St. Johns, NL, Canada

16. Department of Anesthesiology, Critical Care and Pain Medicine, Harvard Medical School, Boston, MA, USA

17. Staff Neurologist, Vall d’Hebron University Hospital, Barcelona, Spain

18. Scientific Steering Committee, International Progressive MS Alliance, Glasgow, UK

19. Scientific Steering Committee, International Progressive MS Alliance, Long Beach, CA, USA

20. Global International Scientific Director, Neuroimmunology, F. Hoffmann-La Roche, Ltd., Basel, Switzerland

21. Department of Psychiatry, University of Toronto and Sunnybrook Health Sciences Centre, Toronto, ON, Canada

Abstract

Background: People with multiple sclerosis (MS) experience myriad symptoms that negatively affect their quality of life. Despite significant progress in rehabilitation strategies for people living with relapsing-remitting MS (RRMS), the development of similar strategies for people with progressive MS has received little attention. Objective: To highlight key symptoms of importance to people with progressive MS and stimulate the design and implementation of high-quality studies focused on symptom management and rehabilitation. Methods: A group of international research experts, representatives from industry, and people affected by progressive MS was convened by the International Progressive MS Alliance to devise research priorities for addressing symptoms in progressive MS. Results: Based on information from the MS community, we outline a rationale for highlighting four symptoms of particular interest: fatigue, mobility and upper extremity impairment, pain, and cognitive impairment. Factors such as depression, resilience, comorbidities, and psychosocial support are described, as they affect treatment efficacy. Conclusions: This coordinated call to action—to the research community to prioritize investigation of effective symptom management strategies, and to funders to support them—is an important step in addressing gaps in rehabilitation research for people affected by progressive MS.

Publisher

SAGE Publications

Subject

Clinical Neurology,Neurology

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3